Trial
NCT05200442
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Verastem, Inc.
Condition
Colorectal Cancer
Intervention
VS-6766/avutometinib
Why stopped
enrollment goal met pending determination of evaluable subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-08